Meta tags:
description=Power drug development with evidence from the world’s largest recontactable genetics community. We provide large-scale genetic evidence from an engaged participant community to support the drug development lifecycle. Biopharma partners collaborate with 23andMe to understand disease biology, identify novel targets, boost clinical trial success, and engage people in their care.;
author=23andMe;

Headings (most frequently used words):

to, research, with, the, community, our, power, drug, development, from, genetics, 23andme, in, 11m, learn, about, we, offer, and, disease, evidence, world, largest, recontactable, partner, conduct, at, unparalleled, scaleour, includes, tomorrow, medicines, are, genes, 3m, 4b, 4m, solutions, engage, participant, explore23, leverage, expertise, impact, case, study, library, has, published, 300, papers, since, 2010, participants, unique, opportunity, help, advance, genetic, discover23, insights23, recruit23, engage23, immunology, alzheimer, parkinson, rare, biomarker, adult, adhd,

Text of the page (most frequently used words):
#research (68), and (63), the (51), 23andme (46), with (38), for (32), that (32), more (31), data (30), participants (24), participant (23), #disease (19), genetic (19), read (18), our (16), from (15), new (15), contact (13), access (13), discover23 (13), study (12), parkinson (12), can (10), you (10), about (9), will (9), over (9), drug (9), people (9), learn (9), risk (9), 000 (9), clinical (9), insights (8), this (8), identify (8), who (7), researchers (7), have (7), cohort (7), novel (7), programs (7), cancer (7), like (7), community (7), scale (7), phenotypes (7), potential (6), collaborators (6), participating (6), how (6), authorized (6), has (6), could (6), through (6), enable (6), studies (6), something (6), world (6), individuals (6), within (5), participate (5), what (5), privacy (5), consented (5), targets (5), development (5), lung (5), means (5), care (5), associated (5), non (5), role (5), discover (5), blood (5), use (4), support (4), additional (4), their (4), only (4), which (4), environment (4), tre (4), analysis (4), lifebit (4), phenotypic (4), power (4), your (4), most (4), provides (4), associations (4), not (4), treatments (4), better (4), understand (4), biology (4), help (4), dna (4), save (4), lives (4), all (4), than (4), largest (4), large (4), studying (4), type (4), identified (4), success (4), evidence (4), trial (4), case (4), engage (4), explore23 (4), solutions (4), any (3), out (3), analyses (3), must (3), they (3), security (3), before (3), trusted (3), wide (3), health (3), leverage (3), while (3), partner (3), its (3), been (3), such (3), these (3), gene (3), partners (3), ability (3), biopharma (3), advance (3), diseases (3), medicines (3), conducted (3), human (3), genome (3), association (3), cohorts (3), points (3), discovery (3), develop (3), debbie (3), pickworth (3), founder (3), braf (3), bombers (3), joining (3), helping (3), discoveries (3), improve (3), detection (3), reduction (3), wouldn (3), exist (3), without (3), millions (3), genetics (3), 145 (3), found (3), previously (3), unreported (3), may (3), act (3), early (3), flags (3), are (3), recruited (3), testing (3), plays (3), major (3), european (3), patients (3), state (3), art (3), double (3), target (3), publications (3), rare (3), 11m (3), please (2), form (2), customer (2), partnerships (2), customers (2), consent (2), information (2), opt (2), sign (2), agreement (2), describes (2), cannot (2), guidelines (2), qualified (2), secure (2), technology (2), range (2), initiatives (2), scientists (2), partnership (2), reports (2), performed (2), securely (2), ensures (2), scalable (2), shared (2), stripped (2), personal (2), identifiers (2), name (2), details (2), generated (2), pooled (2), summaries (2), particular (2), individual (2), effective (2), optimize (2), safety (2), leading (2), experts (2), mission (2), accelerate (2), results (2), gwas (2), 1000 (2), condition (2), were (2), relevant (2), faqs (2), program (2), into (2), next (2), jordan (2), carroll (2), inspiration (2), giving (2), was (2), benefit (2), marginalized (2), black (2), americans (2), potentially (2), privilege (2), feel (2), duty (2), being (2), simple (2), having (2), tested (2), todd (2), fielder (2), want (2), move (2), science (2), forward (2), hopefully (2), come (2), treatment (2), options (2), myself (2), then (2), future (2), generations (2), tony (2), garrett (2), live (2), where (2), big (2), lead (2), breakthroughs (2), method (2), revolutionary (2), accelerating (2), cures (2), conditions (2), much (2), faster (2), those (2), previous (2), offer (2), recontactable (2), factors (2), 210 (2), developed (2), scores (2), asymptomatic (2), likely (2), skin (2), studied (2), map3k15 (2), loss (2), function (2), diabetes (2), lab (2), million (2), finds (2), abo (2), supportive (2), covid (2), susceptibility (2), severity (2), suggesting (2), protective (2), unlike (2), types (2), loci (2), depression (2), descent (2), 450 (2), year (2), prospective (2), longitudinal (2), 110 (2), examines (2), penetrance (2), natural (2), history (2), carry (2), lrrk2 (2), g2019s (2), mutation (2), reported (2), along (2), mapping (2), methods (2), nearly (2), set (2), indication (2), pairs (2), enriched (2), white (2), paper (2), describing (2), analyzes (2), diverse (2), high (2), confidence (2), scientific (2), mirador (2), immune (2), unparalleled (2), gsk (2), collaboration (2), genetically (2), validated (2), under (2), referrals (2), testimonials (2), engage23 (2), recruit (2), based (2), criteria (2), recruit23 (2), uncover (2), insights23 (2), collaborate (2), curated (2), genotyped (2), above, questions, change, status, time, contacting, refer, document, account, settings, vetted, enforces, strict, measures, place, authorizing, does, ensure, powered, demonstrated, experience, safely, handling, sensitive, genomic, different, vision, aligned, ours, creating, flexible, safe, easy, portal, respecting, platform, allows, grant, need, still, preserving, press, release, why, did, choose, built, controls, governance, protections, remains, retains, full, control, restricted, explicitly, company, setup, controlled, upholding, commitment, uses, including, population, level, summary, statistics, pooling, similar, many, reviewed, institutional, review, board, irb, independent, ethics, panel, complies, government, ethical, protect, summarized, typically, highlight, between, variants, risks, used, various, aimed, discovering, apply, anticipate, concerns, drugs, collaborating, aim, understanding, basis, creation, kind, using, builds, harness, benefits, collaborations, focused, manner, done, analyzing, curating, cohesive, medical, believe, best, way, innovative, choice, always, unique, opportunity, view, contributions, published, 300, papers, since, 2010, mark, mckenna, chairman, ceo, supercharges, rapidly, transformational, precision, therapies, living, chronic, mediated, inflammatory, fibrotic, combining, mirador360, cutting, edge, multi, modal, capabilities, database, progress, toward, solving, unmet, needs, john, lepore, former, svp, head, continues, exceed, expectations, portfolio, initiated, shows, least, probability, becoming, today, validation, pre, sites, stage, iii, adult, adhd, local, genotype, person, draws, biomarker, motivated, possess, two, extremely, genotypes, invasive, delivered, precisely, targeted, apoe, phase, tight, timeline, alzheimer, protein, key, response, immunology, see, impact, library, encourage, further, action, diagnostic, educate, trials, signals, deliver, indications, licensing, opportunities, differentiate, expertise, interested, learning, preview, other, leveraging, complete, once, receive, notification, granted, here, educational, awareness, active, base, expert, team, existing, integrate, proprietary, public, datasets, unlocking, drive, explore, ready, enhance, sample, biobanking, ancestry, conduct, includes, provide, engaged, lifecycle, boost, tomorrow, genes, home, collaborator, login, page, international,

Text of the page (random words):
qs power drug development with evidence from the world s largest recontactable genetics community tomorrow s medicines are in our genes we provide large scale genetic evidence from an engaged participant community to support the drug development lifecycle biopharma partners collaborate with 23andme to understand disease biology identify novel targets boost clinical trial success and engage people in their care partner with 23andme to conduct research at unparalleled scale our research community includes 11m consented and genotyped participants 3m consented and genotyped participants of non european ancestry 4b phenotypic data points 4m participants consented to sample biobanking solutions learn about the solutions we offer to power drug development and to engage in research with our 11m participant community discover23 explore analysis ready genome wide association studies gwas conducted on 1000 disease and condition cohorts curated from 4b phenotypic data points to enhance your research program with genetic evidence access curated genetic associations generated through state of the art analysis on data pooled from millions of participants unlocking insights that drive novel target discovery securely access and integrate proprietary and public datasets through a trusted research environment contact us to learn more insights23 collaborate with 23andme s expert scientific team to uncover genetic insights on your existing research programs contact us to learn more recruit23 recruit clinical trial participants based on genetic criteria through our active participant base contact us to learn more engage23 engage our participants through educational disease awareness programs contact us to learn more explore23 interested in learning more explore23 provides a preview of discover23 and other solutions leveraging our 11m participant community for access to explore23 complete this contact form once you receive a notification that you have been granted access access explore23 here leverage genetics expertise to discover23 and insights23 discover novel disease biology and identify new drug targets optimize and differentiate research programs identify new indications and out licensing opportunities uncover safety signals and deliver insights recruit23 recruit relevant participants into clinical trials based on genetic criteria engage23 engage and educate participants about diseases and care programs encourage further action such as additional diagnostic testing case studies testimonials learn about our impact from the case study library see all case studies immunology we identified a novel association for il 18 a protein that plays a key role in immune response alzheimer s disease we delivered precisely targeted referrals for an apoe phase ii clinical trial under a tight timeline parkinson s disease we motivated individuals who possess two extremely rare genotypes to participate in an invasive research study rare biomarker we recruited a cohort of local individuals with a rare genotype for in person blood draws adult adhd we identified pre qualified referrals within range of participating sites for a stage iii clinical trial our collaboration with 23andme continues to exceed expectations with more than 40 genetically validated drug discovery programs in the gsk portfolio that were initiated under the collaboration evidence shows that genetically validated drug targets have at least double the probability of success in becoming medicines today more than 70 of our targets in research have genetic validation john lepore former svp and head of research at gsk our new partnership with 23andme supercharges the mirador mission to rapidly advance transformational precision therapies for patients living with chronic immune mediated inflammatory and fibrotic diseases combining mirador360 s cutting edge biology multi modal data and ai capabilities with the unparalleled genetic and phenotypic insights from the 23andme database will enable us to accelerate our progress toward solving major unmet needs in i i mark c mckenna chairman and ceo of mirador publications 23andme has published 300 papers since 2010 learn more about 23andme s contributions to the scientific community view all publications previous data from a large scale study of over 145 000 research participants found 42 previously unreported phenotypes associated with parkinson s disease that may act as early flags for the disease read more white paper describing how 23andme analyzes the world s largest and most diverse genetic cohort to discover novel high confidence associations read more 23andme s scale of participant reported health data along with state of the art gene mapping methods nearly double the set of target indication pairs enriched for clinical success read more 23andme s 3 5 year prospective longitudinal study on 110 000 research participants examines the clinical phenotypes penetrance and natural history of parkinson s disease patients who carry the lrrk2 g2019s mutation read more 23andme identified 15 genetic loci associated with risk of major depression in individuals of european descent by studying a cohort of over 450 000 research participants read more a study of over 1 million 23andme research participant finds that abo plays a supportive role in covid 19 susceptibility and severity suggesting that blood type o is protective unlike non o blood types read more 23andme studied map3k15 loss of function to understand its role in type 2 diabetes and recruited participants for additional lab testing to discover new phenotypes read more by studying genetic and non genetic risk factors in 210 000 participants 23andme developed risk scores to identify asymptomatic individuals who are likely to develop skin cancer read more data from a large scale study of over 145 000 research participants found 42 previously unreported phenotypes associated with parkinson s disease that may act as early flags for the disease read more white paper describing how 23andme analyzes the world s largest and most diverse genetic cohort to discover novel high confidence associations read more 23andme s scale of participant reported health data along with state of the art gene mapping methods nearly double the set of target indication pairs enriched for clinical success read more 23andme s 3 5 year prospective longitudinal study on 110 000 research participants examines the clinical phenotypes penetrance and natural history of parkinson s disease patients who carry the lrrk2 g2019s mutation read more 23andme identified 15 genetic loci associated with risk of major depression in individuals of european descent by studying a cohort of over 450 000 research participants read more a study of over 1 million 23andme research participant finds that abo plays a supportive role in covid 19 susceptibility and severity suggesting that blood type o is protective unlike non o blood types read more 23andme studied map3k15 loss of function to understand its role in type 2 diabetes and recruited participants for additional lab testing to discover new phenotypes read more by studying genetic and non genetic risk factors in 210 000 participants 23andme developed risk scores to identify asymptomatic individuals who are likely to develop skin cancer read more data from a large scale study of over 145 000 research participants found 42 previously unreported phenotypes associated with parkinson s disease that may act as early flags for the disease read more next contact contact us to learn more about how you can leverage the world s largest recontactable genetics community to power your drug development programs for 23andme research participants we offer research participants a unique opportunity to help advance genetic research previous joining a research study means helping enable discoveries that could improve detection risk reduction and care that wouldn t exist without people like you participating debbie pickworth founder braf bombers 23andme lung cancer research participant we live in a new world where data big data from millions of people like you and me could lead to new breakthroughs that save people s lives this new method of research is revolutionary it has the potential of accelerating treatments and cures for conditions like parkinson s and to do that much faster than before for those of us with parkinson s that means something tony garrett 23andme parkinson s disease research participant i want to participate in research to help move science forward to hopefully come up with new treatment options if not for myself then for future generations todd fielder 23andme lung cancer research participant my inspiration for giving my dna to this research was to benefit marginalized black americans the ability to potentially save lives is a privilege and something that i feel is my duty as a human being if i can do this with something as simple as having my dna tested all the better jordan carroll 23andme research participant joining a research study means helping enable discoveries that could improve detection risk reduction and care that wouldn t exist without people like you participating debbie pickworth founder braf bombers 23andme lung cancer research participant we live in a new world where data big data from millions of people like you and me could lead to new breakthroughs that save people s lives this new method of research is revolutionary it has the potential of accelerating treatments and cures for conditions like parkinson s and to do that much faster than before for those of us with parkinson s that means something tony garrett 23andme parkinson s disease research participant i want to participate in research to help move science forward to hopefully come up with new treatment options if not for myself then for future generations todd fielder 23andme lung cancer research participant my inspiration for giving my dna to this research was to benefit marginalized black americans the ability to potentially save lives is a privilege and something that i feel is my duty as a human being if i can do this with something as simple as having my dna tested all the better jordan carroll 23andme research participant joining a research study means helping enable discoveries that could improve detection risk reduction and care that wouldn t exist without people like you participating debbie pickworth founder braf bombers 23andme lung cancer research participant next we believe the best way to develop new and more effective treatments is through innovative partnerships with leading experts the choice to opt into or out of research is always up to the participant learn about our research program faqs what is discover23 discover23 builds on 23andme s mission to help more people harness the benefits of the human genome it will enable collaborations with biopharma partners in a scalable and privacy focused manner to accelerate research discover23 provides the results of genome wide association studies gwas conducted on over 1000 disease and condition cohorts these studies were done by 23andme scientists analyzing 4b data points curating cohesive cohorts most relevant for medical research and drug discovery discover23 provides summaries of research results which do not identify any particular individual with authorized research collaborators what kind of research will be conducted using discover23 authorized collaborators will have the ability to use discover23 insights for various research initiatives aimed at discovering new and more effective treatments these research insights enable biopharma collaborators to better understand disease biology identify novel drug targets apply genetic insights to optimize research programs and anticipate potential safety concerns for drugs in development by collaborating with leading experts we aim to advance understanding of the genetic basis of diseases and support the creation of better medicines what data will be shared with partners through discover23 authorized collaborators will have access to summarized reports of analyses performed on pooled data that has been stripped of personal identifiers such as name and contact details these summaries typically highlight associations between gene variants and disease risks and do not identify any particular individual only data from 23andme customers who have consented to participate in research will be used in analyses how do you protect participant privacy 23andme research uses data that has been stripped of personal identifiers such as name and contact details most research including discover23 provides population level summary statistics generated by pooling similar information from many research participants 23andme s research is reviewed by an institutional review board irb an independent ethics panel that ensures research complies with government and ethical guidelines how will data be shared with collaborators authorized researchers will access data and reports within a secure trusted research environment tre with built in access controls and data governance protections data remains within the tre so that analysis can be performed securely potential researchers must sign an agreement which describes what they can and cannot do with research data 23andme retains full control over data in the tre and its use is restricted to researchers explicitly authorized by the company this setup ensures scalable controlled access while upholding our commitment to participant privacy and data security why did you choose lifebit as your technology partner 23andme s trusted research environment tre the secure environment for data analysis is powered by technology from lifebit lifebit has demonstrated experience in safely handling sensitive genomic and phenotypic data from a wide range of different health initiatives their vision aligned with ours in creating a flexible safe and easy to use portal within which researchers could leverage the power of the 23andme research cohort while respecting participant privacy their platform allows 23andme to grant scientists access to only the discover23 research insights that they need while still preserving the privacy and security of our consented research cohort read more about our partnership with lifebit in our press release does 23andme have guidelines to ensure only qualified researchers can access participant data only vetted and authorized researchers can access discover23 analyses potential researchers must sign an agreement which describes what they can and cannot do with participant data 23andme enforces strict data security measures that must be in place before authorizing access how can i participate in research or opt out of participating customers can change their consent status at any time within account settings or by contacting customer support for more information about participating in research refer to the research consent document who do i contact with additional questions abou...